Tan Qin,Zhang Mingman.Research progress on prognostic factors of hepatoblastoma in children[J].Journal of Clinical Pediatric Surgery,,20():474-477.[doi:10.12260/lcxewkzz.2021.05.015]
Click Copy

Research progress on prognostic factors of hepatoblastoma in children

References:

1 Kehm RD,Osypuk TL,Poynter JN,et al.Do pregnancy characteristics contribute to rising childhood cancer incidence rates in the United States?[J].Pediatr Blood Cancer,2018,65(3):10.1002/pbc.26888.DOI:10.1002/pbc.26888.
2 Hung GY,Lin LY,Yu TY,et al.Hepatoblastoma incidence in Taiwan:A population-based study[J].J Chin Med Assoc,2018,81(6):541-547.DOI:10.1016/j.jcma.2017.11.012.
3 Towbin AJ,Meyers RL,Woodley H,et al.2017 PRETEXT:radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT)[J].Pediatr Radiol,2018,48(4):536-554.DOI:10.1007/s00247-018-4078-z.
4 Feng J,Polychronidis G,Heger U,et al.Incidence trends and survival prediction of hepatoblastoma in children:a population-based study[J].Cancer Commun (Lond),2019,39(1):62.DOI:10.1186/s40880-019-0411-7.
5 Feng J,He Y,Wei L,et al.Assessment of Survival of Pediatric Patients With Hepatoblastoma Who Received Chemotherapy Following Liver Transplant or Liver Resection[J].JAMA Netw Open,2019,2(10):e1912676.DOI:10.1001/jamanetworkopen.2019.12676.
6 Van Tornout JM,Buckley JD,Quinn JJ,et al.Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome:a report from the Children’s Cancer Group[J].J Clin Oncol,1997,15(3):1190-1197.DOI:10.1200/JCO.1997.15.3.1190.
7 Cai HY,Yu B,Feng ZC,et al.Clinical significance of CD44 expression in children with hepatoblastoma[J].Genet MolRes,2015,14(4):13203-13207.DOI:10.4238/2015.October.26.16.
8 Kiruthiga KG,Ramakrishna B,Saha S,et al.Histological and immunohistochemical study of hepatoblastoma:correlation with tumour behaviour and survival[J].J Gastrointest Oncol,2018,9(2):326-337.DOI:10.21037/jgo.2018.01.08.
9 中华医学会病理学分会儿科病理学组,福棠儿童医学发展研究中心病理专业委员会.肝母细胞瘤病理诊断专家共识[J].中华病理学杂志,2019,48(3):176-181.DOI:10.3760/cma.j.issn.0529-5807.2019.03.002. Group of Pediatric Pathology,Branch of Pathology,Chinese Medical Association;Pathology Specialist Committee of Futang Research Center of Pediatric Development:Chinese expert group consensus on pathological diagnosis of hepatoblastoma[J].Chin J Pathol,2019,48(3):176-181.DOI:10.3760/cma.j.issn.0529-5807.2019.03.002.
10 Lim ⅡP,Bondoc AJ,Geller JI,et al.Hepatoblastoma The Evolution of Biology,Surgery,and Transplantation[J].Children (Basel),2018,6(1):1.DOI:10.3390/children6010001.
11 Kremer N,Walther AE,Tiao GM.Management of hepatoblastoma:an update[J].Curr Opin Pediatr,2014,26(3):362-369.DOI:10.1097/MOP.0000000000000081.
12 Meyers RL,Maibach R,Hiyama E,et al.Risk-stratified staging in paediatric hepatoblastoma:a unified analysis from the Children’s Hepatic tumors International Collaboration[J].Lancet Oncol,2017,18(1):122-131.DOI:10.1016/S1470-2045(16)30598-8.
13 Czauderna P,Haeberle B,Hiyama E,et al.The Children’s Hepatic tumors International Collaboration (CHIC):Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model[J].Eur J Cancer,2016,52:92-101.DOI:10.1016/j.ejca.2015.09.023.
14 Koh KN,Park M,Kim BE,et al.Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma[J].Pediatr Blood Cancer,2011,57(4):554-560.DOI:10.1002/pbc.23069.
15 Wang TY,Han YL,Gao YJ,et al.Retrospective Analysis of Childhood Hepatoblastoma in a Single Centre in China[J].Clin Oncol (R Coll Radiol),2019,31(7):471-478.DOI:10.1016/j.clon.2019.03.044.
16 王大斌,张可仞,贾慧敏,等.影响肝母细胞瘤儿童术后生存的因素分析[J].国际儿科学杂志,2019,46(8):612-616.DOI:10.3760/cma.j.issn.1673-4408.2019.08.017. Wang DB,Zhang KQ,Jia HM,et al.Analysis of factors affecting postoperative survival of children with hepatoblastoma[J].Int J Pediatr,2019,46(8):612-616.DOI:10.3760/cma.j.issn.1673-4408.2019.08.017.
17 Maibach R,Roebuck D,Brugieres L,et al.Prognostic stratification for children with hepatoblastoma:the SIOPEL experience[J].Eur J Cancer,2012,48(10):1543-1549.DOI:10.1016/j.ejca.2011.12.011.
18 葛丽丽,宋银森,张现伟.肝母细胞瘤甲胎蛋白、病理学标志物的表达变化与预后的关系[J].实验与检验医学,2019,37(1):18-22.DOI:10.3969/j.issn.1674-1129.2019.01.006. Ge LL,Song YS,Zhang XW.The relationship between the expression of alpha-fetoprotein and pathological markers and prognosis in hepatoblastoma[J].Experimental and Laboratory Medicine,2019,37(1):18-22.DOI:10.3969/j.issn.1674-1129.2019.01.006.
19 Peng HX,Yang L,He BS,et al.Combination of preoperative NLR,PLR and CEA could increase the diagnostic efficacy for I-Ⅲ stage CRC[J].J Clin Lab Anal,2017,31(5):e22075.DOI:10.1002/jcla.22075.
20 Peng H,Luo X.Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer:a meta-analysis[J].Cancer Cell Int,2019,19:70.DOI:10.1186/s12935-019-0785-2.
21 Wang TY,Han YL,Gao YJ,et al.Retrospective Analysis of Childhood Hepatoblastoma in a Single Centre in China[J].Clin Oncol (R Coll Radiol),2019,31(7):471-478.DOI:10.1016/j.clon.2019.03.044.
22 姚东亚,罗源,盛光耀.儿童肝母细胞瘤36例预后分析[J].临床儿科杂志,2017,35(2):121-124.DOI:10.3969/j.issn.1000-3606.2017.02.011. Yao DY,Luo Y,Sheng GY.Prognostic analysis of hepatoblastoma in children[J].Journal of Clinical Pediatrics,2017,35(2):121-124.DOI:10.3969/j.issn.1000-3606.2017.02.011.
23 Dall’Igna P,Brugieres L,Christin AS,et al.Hepatoblastoma in children aged less than six months at diagnosis:A report from the SIOPEL group[J].Pediatr Blood Cancer,2018,65(1):10.1002/pbc.26791.DOI:10.1002/pbc.26791.
24 吴琳琳,禚孝颖,刘洁,等.行根治性切除术的儿童肝母细胞瘤54例预后因素分析[J].精准医学杂志,2020,35(2):138-141.DOI:10.13362/j.jpmed.202002011. Wu LL,Luo XY,Liu J,et al.Analysis of prognostic factors in 54 children with hepatoblastoma undergoing radical resection[J].J Precis Med,2020,35(2):138-141.DOI:10.13362/j.jpmed.202002011.
25 张谊,黄东生,张伟令,等.IN1基因表达与儿童肝母细胞瘤临床特点及预后的相关性研究[J].中华实用儿科临床杂志,2019,34(15):1156-1159.DOI:10.3760/cma.j.issn.2095-428X.2019.15.008. Zhang Y,Huang DS,Zhang WL,et al.Study on the relationship between IN1 gene expression and clinical characteristics and prognosis of hepatoblastoma in children[J].Chin J Appl Clin Pediatr,2019,34(15):1156-1159.DOI:10.3760/cma.j.issn.2095-428X.2019.15.008.
26 Perilongo G,Malogolowkin M,Feusner J.Hepatoblastoma clinical research:lessons learned and future challenges[J].Pediatr Blood Cancer,2012,59(5):818-821.DOI:10.1002/pbc.24217.
27 杨维,任清华,秦红,等.儿童肝母细胞瘤精准肝切除手术效果评价[J].临床小儿外科杂志,2020,19(5):392-397.DOI:10.3969/j.issn.1671-6353.2020.05.004. Yang W,Ren QH,Qin H,et al.Evaluation of the effect of precision hepatectomy in children with hepatoblastoma[J].J Clin Ped Sur,2020,19,(5):392-397.DOI:10.3969/j.issn.1671-6353.2020.05.004.

Memo

收稿日期:2020-10-04。
基金项目:重庆市科学技术局资助项目(编号:cstc2018jscx-msyb0182)
通讯作者:张明满,Email:zhangmingman-a@163.com

Last Update: 1900-01-01